Professor Michel Michaelides


  • Fee assured

This healthcare professional let us know that they are currently:

  • Accepting new patients
  • Available for:
    • Phone consultations
    • Video consultations

Last updated: 5 Jun 2020

Specialises in

  • Medical

About me

Michel Michaelides is a Consultant Ophthalmologist at Moorfields Eye Hospital in the departments of Medical Retina, Inherited Eye Disease and Paediatric Ophthalmology; and is a Department of Health funded Professor of Ophthalmology at the UCL Institute of Ophthalmology. He is a recipient of a career development award from the Foundation Fighting Blindness (USA) – an award which is rarely given to non-US applicants; and has gained membership of the highly prestigious Macula Society in the USA.

He has undertaken a medical retina and genetics clinical fellowship at Moorfields Eye Hospital, and a combined ophthalmic genetics and paediatric ophthalmology clinical and research fellowship at the internationally renowned Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA.

He undertook a period of dedicated research (2002-2004), with his doctoral thesis entitled: ‘Cone and Central Receptor Dystrophies – A Clinical and Molecular Genetic Investigation’.

His clinical and research interests include diabetic eye disease, age-related macular degeneration and inherited eye disease in adults and children; with over 90 peer-reviewed publications and 14 co-authored book chapters. He collaborates closely with Professors Robin Ali and James Bainbridge in the UK and Professors Joe Carroll and Richard Weleber in the USA, culminating in multiple publications and presentations relating to both acquired and inherited retinal disease and the development of new treatments. He is actively involved in retinal clinical trials investigating novel and established therapies, being a principal investigator in 6 on-going clinical trials.

Areas of interest

Diabetic Retinopathy
Macular Degeneration

Medical Retina (including diabetic retinopathy, retinal vein occlusions, and age-related macular degeneration).

Expertise in the use of Lucentis, Avastin and Eylea for the treatment of age-related macular degeneration and diabetic eye disease; and Photodynamic therapy (PDT) for selected retinal disorders including central serous retinopathy.

Inherited Eye Disease in adults and children (including Retinitis Pigmentosa, Stargardt macular dystrophy, Leber Congenital Amaurosis, Macular Dystrophies, Cone-Rod and Cone Dystrophies).

General Ophthalmology (including red eye).

Medical secretaries

About me
About my work
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • C7923

    Intravitreal injection of pharmaceutical for neovascular age related macular degeneration - (1-5)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.